Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

World’s Highest Field 21 Tesla Magnet Installed

Published: Monday, June 16, 2014
Last Updated: Monday, June 16, 2014
Bookmark and Share
The FT-ICR Mass Spectrometry magnet has been installed at National High Magnetic Field Laboratory (NHMFL).

Bruker Corporation and the National High Magnetic Field Laboratory at Florida State University today announced the successful installation of the world’s first 21 Tesla (T) magnet for Fourier Transform Ion Cyclotron Resonance (FT-ICR).  The installation represents the world’s highest field, persistent, superconducting magnet suitable for FT-ICR mass spectrometry, which is also often referred to as FTMS. The 21T magnet was designed and built by Bruker in collaboration with NHMFL scientists, and will be used in the NHMFL FT-ICR program in a project funded by the National Science Foundation, which makes cutting edge FT-ICR technologies available to the larger community of scientists.

FT-ICR is by far the highest resolution mass spectrometry technique available, and is useful in the analysis of extremely complex mixtures, including applications in petroleomics, dissolved organic matter (DOM), metabolomics, top-down proteomics, and MALDI imaging.  The performance of FT-ICR systems improves with increasing magnetic field, and the 21T magnet is expected to enable further dramatic improvements in mass resolution, mass accuracy and dynamic range compared to the previous highest field of 15T.  The ICR Program at the NHMFL is a world leader in instrument and technique development, as well as the pursuit for novel applications of FT-ICR mass spectrometry.  

Professor Alan Marshall, the Robert O. Lawton Professor of Chemistry and Biochemistry at Florida State University and Director of the High Field FT-ICR program at the NHMFL, commented: “We are delighted to report that the 21T Bruker magnet is at full field.  The other subsystems of the 21T FT-ICR mass spectrometer have been designed and are currently being assembled, for availability targeted for early fall of 2014.”

Professor Marshall added: “Three primary science drivers for this instrument are:  (a) faster throughput without loss of mass resolution for top-down proteomics; (b) extension of the size and complexity of protein complexes whose contact surfaces are mapped by solution-phase hydrogen/deuterium exchange, and (c) improved mass resolution and dynamic range for characterizing compositionally complex organic mixtures (petroleum, dissolved organic matter, metabolome).  The higher magnetic field should result in dramatic improvement (by factors of 40-100%) in FT-ICR MS figures of merit, including mass resolution and resolving power, mass accuracy, dynamic range, and data acquisition speed.”

The 21 T magnet design offers a 110 mm room temperature horizontal bore, with fringe field profiles and room temperature bore access optimized for FT-ICR MS.  It includes many design features pioneered by Bruker, including operation at ~2 Kelvin by use of Bruker’s unique UltraStabilized™ sub-cooling technology, the UltraShield™ technology to reduce stray fields, as well as novel active magnet refrigeration technology that virtually eliminates cryogen refills and user maintenance of the magnet.  In addition to FTMS, the 21T magnet is also suitable for ultra-high field preclinical MRI for highest sensitivity and resolution in mouse neuroimaging.

Dr. Gerhard Roth, the Bruker Ultra-High Field Magnet Manager, said: “The 21T FT-ICR magnet is based on the wealth of experience gathered in ultra-high field magnet technology for NMR and for MRI magnets.  Bruker is extremely pleased to supply this cutting-edge 21T magnet to enable new scientific research directions in ultra-high field FT-ICR mass spectrometry.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Full Range of Bruker Systems Installed in New Pre-Clinical Imaging Laboratory
Researchers, clinicians, health educators and policy makers all gathered as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP).
Thursday, June 18, 2015
UK National Graphene Institute Selects Bruker as Official Partner
World-leading graphene research facility purchases multiple Bruker AFMs.
Tuesday, April 07, 2015
PREMIER Biosoft Announces Reseller Agreement with Bruker
Agreement aims to advance lipidomics and metabolomics research.
Monday, November 17, 2014
Bruker Sells GC Business
Bruker completed the divestiture of its GC and GC single-quadrupole (GC-SQ) mass spectrometry products to Techcomp Europe Ltd on October 31st.
Tuesday, November 04, 2014
Bruker Awarded Fourth PeakForce Tapping Patent
AFM mode uniquely combines highest resolution imaging and material property mapping.
Thursday, July 24, 2014
Using LC-MS to Analyse Sulfonamides in Food Grade Honey
Sulfonamides are one of a number of groups of chemicals whose presence in honey is limited by international regulations.
Tuesday, July 22, 2014
Bruker MALDI Biotyper™ Receives CFDA Clearance
Company receives clearance from the China Food and Drug Administration to market and sell its IVD MALDI Biotyper System as a medical device in China for the identification of microorganisms isolated from human specimens.
Thursday, June 26, 2014
Bruker Reports 7% Revenue Growth in Q4
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
Wednesday, February 19, 2014
Bruker Opens New Preclinical Imaging Center of Excellence for the Americas
Massachusetts Center will provide advanced development, demonstration and customer support capabilities for Bracer’s unique multimodal preclinical imaging systems portfolio.
Thursday, January 30, 2014
Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group.
Monday, January 20, 2014
World’s First Compact 900 MHz Actively Refrigerated Magnet for NMR Installed at UCSD
Bruker announce the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration.
Wednesday, December 11, 2013
Bruker Granted FDA Clearance to Market the MALDI Biotyper CA System
Bruker able to market MALDI Biotyper CA System in the US for the identification of Gram negative bacterial colonies cultured from human specimens.
Tuesday, November 26, 2013
Bruker and SISCAPA Assay Technologies Announce Second-Phase Collaboration Agreement
The ongoing collaboration aims to exploit MALDI-TOF instruments as an alternative to nano-LC-MS technology currently used in many SISCAPA assays.
Monday, September 16, 2013
Bruker Announces Acquisition of Prairie Technologies
Acquisition strengthens Bruker Nano Surfaces Division's position in life science markets.
Friday, September 13, 2013
Novel Approach for Inborn Errors of Metabolism Screening by NMR
Clinical IEM-by-NMR screening study in Turkey measures 65 metabolites in urine simultaneously, including 20 endogeneous metabolites and 45 metabolites associated with inborn errors of metabolism.
Wednesday, September 04, 2013
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!